The global Plasma Protein Therapeutic Market is poised for substantial growth, driven by rising prevalence of chronic diseases, increasing demand for immunoglobulins, and advancements in biopharmaceutical technologies. Plasma-derived therapies remain a critical segment of modern medicine, catering to patients with bleeding disorders, immune deficiencies, and neurological conditions. The...